Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia (Acute)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07809906
What this trial is testing

Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

Who this might be right for
CD123+ Acute Myeloid Leukemia
Orum Therapeutics USA, Inc. 42
Not applicableStudy completedNCT04452604
What this trial is testing

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

Who this might be right for
Acute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaSARS-CoV-2
French Innovative Leukemia Organisation 79
Post-approval studies (Phase 4)UnknownNCT04446806
What this trial is testing

Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07636564
What this trial is testing

Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

Who this might be right for
Acute Leukemia of Ambiguous LineageB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative+1 more
SWOG Cancer Research Network 90
Testing effectiveness (Phase 2)Ended earlyNCT02648932
What this trial is testing

The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Chicago 9
Not applicableStudy completedNCT04253314
What this trial is testing

The Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 51
Large-scale testing (Phase 3)UnknownNCT02172872
What this trial is testing

"InDACtion" vs "3+7" Induction in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
European Organisation for Research and Treatment of Cancer - EORTC 606
Testing effectiveness (Phase 2)Study completedNCT02190695
What this trial is testing

Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myelomonocytic Leukemia
Fox Chase Cancer Center 92
Testing effectiveness (Phase 2)Looking for participantsNCT04684147
What this trial is testing

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06982274
What this trial is testing

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo 115
Very early researchLooking for participantsNCT06735690
What this trial is testing

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT02719574
What this trial is testing

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome
Forma Therapeutics, Inc. 336
Not applicableNot Yet RecruitingNCT06906380
What this trial is testing

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, in Relapsed or RefractoryMDS (Myelodysplastic Syndrome)
ARCE Therapeutics, Inc. 49
Early research (Phase 1)UnknownNCT05703204
What this trial is testing

QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Qilu Pharmaceutical Co., Ltd. 122
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Early research (Phase 1)Looking for participantsNCT06080191
What this trial is testing

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Bambino Gesù Hospital and Research Institute 24
Early research (Phase 1)Looking for participantsNCT07751991
What this trial is testing

CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

Who this might be right for
AML (Acute Myeloid Leukemia)
Charm Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT05557110
What this trial is testing

Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL

Who this might be right for
B Acute Lymphoblastic Leukemia
Chen Suning 35
Not applicableStudy completedNCT05021159
What this trial is testing

Assessing the Ontogeny of P-glycoprotein Expression in Blood of Pediatric Leukemic Patients

Who this might be right for
Acute Lymphocytic Leukemia
Tanta University 20
Testing effectiveness (Phase 2)Looking for participantsNCT04687176
What this trial is testing

Frontline Oral Arsenic Trioxide for APL

Who this might be right for
Acute Promyelocytic Leukemia
The University of Hong Kong 100
Next Page